Merit Medical's Wrapsody gains FDA designation

By staff writers

November 22, 2019 -- Disposable products developer Merit Medical Systems has received a breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Wrapsody endovascular stent graft system, the company announced in a statement.

Wrapsody is a flexible, self-expanding endoprosthesis. Though the system is not yet available for sale, Merit intends to seek indication for its use in hemodialysis patients.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking